BioCentury
ARTICLE | Clinical News

Misoprostol vaginal insert regulatory update

October 29, 2012 7:00 AM UTC

FDA accepted for review an NDA from Ferring for misoprostol vaginal insert (MVI) to decrease the time to vaginal delivery in women undergoing labor with an unfavorable cervix when used in sequential r...